Invention Grant
US08546375B2 (3-(4-(aminomethyl)phenoxy or phenylthio)azetidin-1-yl)(5-phenyl-1,3,4-oxadiazol-2-yl)methanone compounds
失效
(3-(4-(氨基甲基)苯氧基或苯硫基)氮杂环丁烷-1-基)(5-苯基-1,3,4-恶二唑-2-基)甲酮化合物
- Patent Title: (3-(4-(aminomethyl)phenoxy or phenylthio)azetidin-1-yl)(5-phenyl-1,3,4-oxadiazol-2-yl)methanone compounds
- Patent Title (中): (3-(4-(氨基甲基)苯氧基或苯硫基)氮杂环丁烷-1-基)(5-苯基-1,3,4-恶二唑-2-基)甲酮化合物
-
Application No.: US13176554Application Date: 2011-07-05
-
Publication No.: US08546375B2Publication Date: 2013-10-01
- Inventor: Susanne Doris Margit Bökman-Winiwarter , Marlene Fredenwall , Carl Anders Hogner , Lars Anders Mikael Johansson , Robert Andrew Judkins , Lanna Li , Björn Christian Ingvar Löfberg , Sverker Von Unge
- Applicant: Susanne Doris Margit Bökman-Winiwarter , Marlene Fredenwall , Carl Anders Hogner , Lars Anders Mikael Johansson , Robert Andrew Judkins , Lanna Li , Björn Christian Ingvar Löfberg , Sverker Von Unge
- Applicant Address: SE Södertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Södertalje
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: A61K31/4245
- IPC: A61K31/4245 ; C07D295/155 ; C07D413/12 ; C07D205/04 ; C07D413/14 ; C07D295/096

Abstract:
Disclosed herein are azetidinyl compounds of formula I, as described herein, pharmaceutical compositions comprising an azetidinyl compound, and a method of using an azetidinyl compound in the treatment or prophylaxis of a melanin-concentrating hormone related disease or condition.
Public/Granted literature
Information query